-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

902.O1.6 902. Health Services and Quality—Lymphoid Malignancies: Real World Consequences and Cost of Care

Symposia: Health Services and Quality—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, adult, Clinical Practice (Health Services and Quality), Lymphomas, CLL, non-Hodgkin lymphoma, epidemiology, elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Combination therapy, Clinical Research, health outcomes research, health disparities research, Diseases, drug-drug interactions, Therapies, therapy sequence, real-world evidence, Adverse Events, Lymphoid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 2:45 PM-4:15 PM
La Nouvelle Orleans Ballroom AB (Ernest N. Morial Convention Center)
Ja Min Byun, MD, PhD, Seoul National University Hospital and Urshila Durani, MD, MPH, Mayo Clinic
No relevant conflicts of interest to declare.
Moderators: Urshila Durani, Ja Min Byun

Back-up: Carla Casulo

2:45 PM

Neda Alrawashdh, PharmD1*, Ali McBride2,3 and Ivo Abraham, PhD, RN4

1Center for Health Outcomes and Pharmacoeconomic Research, university of arizona, TUCSON, AZ
2Division of Hematology/Oncology, Department of Pharmacy, The University of Arizona Cancer Center, Tucson, NJ
3Bristol Myers Squibb, Princeton, NJ
4Center for Health Outcomes and PharmacoEconomic Research, University of Arizona - College of Pharmacy, Tucson, AZ

3:00 PM

Kimberly Guinan, MSc1*, Jean Lachaine, PhD1,2*, Nancy Paul Roc, MSc3*, Sarah-Jane Bull, PhD4*, Dipti Tankala, PharmD, MPharm, MBA3*, Stéphane Barakat, PhD3*, Christopher M. Hillis, MD5 and Versha Banerji, MD6,7

1PeriPharm Inc., Montreal, QC, Canada
2Faculty of pharmacy, Université de Montréal, Montreal, QC, Canada
3AbbVie Corporation, Saint-Laurent, QC, Canada
4Medical Affairs, AbbVie Corporation, Saint-Laurent, QC, Canada
5Faculty of Medicine, McMaster University, Hamilton, ON, Canada
6CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada
7Departments of Internal Medicine and Biochemistry & Medical Genetics, Rady Faculty of Health Sciences, Winnipeg, MB, Canada

3:15 PM

Tuan Hoang, MD, PhD1*, Matthew C. Cheung, MD, MSc1,2,3,4, Kelvin KW Chan, MD, MSc, PhD1,2,3,4*, Cindy Lau, MPH2*, Ning Liu, MSc, PhD2*, Husam Abdel-Qadir, MD, PhD1,5*, David Juurlink, MD, PhD1,2,4*, Anca Prica, MD, MSc1,6, Alia Thawer, PharmD3*, Abi Vijenthira, MD1,6 and Lee Mozessohn1,2,4,7

1Department of Medicine, University of Toronto, Toronto, ON, Canada
2ICES, Toronto, ON, Canada
3Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
4Sunnybrook Research Institute, Toronto, ON, Canada
5Peter Munk Cardiac Center, University Health Network, Toronto, ON, Canada
6Princess Margaret Cancer Centre, Toronto, ON, Canada
7Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

3:30 PM

Chendi Cui1*, Chaoling Feng, PhD2*, Ning Rosenthal, MD, MPH, PhD3*, Sally W Wade, MPH4*, Laura Curry, MS, PhD3*, Christine Fu, PhD5* and Gunjan L. Shah, MD6

1PINC AI Applied Sciences, Premier Inc., Wexford, PA
2Kite, A Gilead Company, Santa Monica, CA
3PINC AI Applied Sciences, Premier Inc., Charlotte, NC
4Wade Outcomes Research and Consulting, Salt Lake City, UT
5Kite, a Gilead Company, Santa Monica, CA
6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

3:45 PM

Matilde Slot, MSc1,2*, Carsten Utoft Niemann, MD, PhD3, Bettina Wulff Risør, PhD1,2*, Lars Holger Ehlers, PhD1* and Emelie Rotbain, MD3,4*

1Nordic Institute of Health Economics, Aarhus, Denmark
2Department of Clinical Medicine, Aalborg University, Aalborg Ø, Denmark
3Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
4Danish Cancer Society Research Center, Copenhagen, DNK

4:00 PM

Judy Truong, MD1, Soo Jin Seung2*, Christoffer Dharma3*, Stephanie Y Cheng4*, Craig Earle, MD, FASCO3*, Simron Singh, MD, MPH5,6*, Nicole Mittman, PhD4* and Matthew C. Cheung, MD, MSc6

1University of Toronto, North York, ON, Canada
2Sunnybrook Research Institute, Toronto, Canada
3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
4Institute for Clinical Evaluative Sciences, Toronto, Canada
5ICES, Toronto, ON, Canada
6Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

*signifies non-member of ASH